227 related articles for article (PubMed ID: 9381277)
1. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Antich Rojas J; Balaguer H; Cladera A
Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
[No Abstract] [Full Text] [Related]
2. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
[TBL] [Abstract][Full Text] [Related]
3. Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: successful treatment with rituximab.
Smolej L; Belada D; Cermanová M; Maisnar V; Lunáková E
Leuk Res; 2010 May; 34(5):e140-1. PubMed ID: 20053448
[No Abstract] [Full Text] [Related]
4. Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia.
MacCallum S; Groves M; Brass D; Cunningham J; Sales M; Gelly K; Tauro S
J Clin Pathol; 2009 May; 62(5):468-70. PubMed ID: 19398596
[TBL] [Abstract][Full Text] [Related]
5. [Cyclosporin A in the treatment of acquired erythroblastopenia in the course of B-cell chronic lymphatic leukemia].
Areal Méndez C; Lite Alvarez JM; Sánchez Varela JM
Sangre (Barc); 1991 Jun; 36(3):237-8. PubMed ID: 1948544
[TBL] [Abstract][Full Text] [Related]
6. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ
Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Schmitt B; Wendtner CM; Bergmann M; Busch R; Franke A; Pasold R; Schlag R; Hopfinger G; Hiddemann W; Emmerich B; Hallek M
Clin Lymphoma; 2002 Jun; 3(1):26-35. PubMed ID: 12141952
[TBL] [Abstract][Full Text] [Related]
8. Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
Sandra S; Real E; Pastor E; Grau E
Haematologica; 1999 Dec; 84(12):1154-5. PubMed ID: 10586218
[No Abstract] [Full Text] [Related]
9. [Chronic lymphatic leukemia and Hodgkin's disease].
Calvo Villas J; Ramírez Sánchez M; Sicilia Guillén F
Sangre (Barc); 1999 Oct; 44(5):393-4. PubMed ID: 10618924
[No Abstract] [Full Text] [Related]
10. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
11. Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma.
Palomera L; Azaceta G; Varo MJ; Soria J; Gutierrez M
Haematologica; 1998 Nov; 83(11):1045-6. PubMed ID: 9864929
[TBL] [Abstract][Full Text] [Related]
12. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
13. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
Binet JL
Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
[No Abstract] [Full Text] [Related]
14. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
15. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
Garratty G; Petz LD
Br J Haematol; 2007 Nov; 139(4):622-3. PubMed ID: 17979948
[No Abstract] [Full Text] [Related]
16. [Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
Koffi KG; Nanho DC; Tolo A; N'Dathz E; Kouakou B; Meite N; Ayemou R; Sanogo I
Bull Cancer; 2009 Sep; 96(9):901-6. PubMed ID: 19696007
[TBL] [Abstract][Full Text] [Related]
17. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
Tsuji T; Hirano T; Yamasaki H; Tuda H
Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
[TBL] [Abstract][Full Text] [Related]
18. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
Ayyildiz O; Isikdogan A; Bolaman Z; Muftuoglu E
Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
[No Abstract] [Full Text] [Related]
19. A challenge to the claims that fludarabine and cyclophosphamide is the new standard treatment for chronic lymphocytic leukaemia.
Haines I; Elliott P; Stanley R
Intern Med J; 2009 Apr; 39(4):269-71. PubMed ID: 19402870
[No Abstract] [Full Text] [Related]
20. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]